Hutch News

Antibody-Targeted Chemotherapy with Mylotarg Shows Promise for Many Adults with Deadly Form of Leukemia

Antibody-Targeted Chemotherapy with Mylotarg Shows Promise for Many Adults with Deadly Form of Leukemia

Fred Hutchinson Cancer Research Center Researcher Presents Updated Study Results at the American Society of Clinical Oncology Meeting in New Orleans
News ReleasesMay 21, 2000